Luis Martin

Biography

Dr. Martin has held several executive positions at PREVENT before becoming the Chief Executive Officer. He brings to the group over 20 years of experience in commercial biotechnology. Prior to joining PREVENT, Dr. Martin was Chief Development and QA Officer at Mitomics where he was responsible for managing new product development, the clinical trial programs, and directing the implementation of a Quality Assurance program. Previously he was also the managing director and founder of Lumar Management Consulting Inc. (LMCI), a company providing operational management and executive mentoring to emerging biotechnology companies. Dr. Martin previously held various senior management positions at biotechnology companies including, director of research and development at Arius Research Inc.; vice president, research and development at GENSEL Biotechnologies Inc.; and director of immunobiology at Biomira Inc. He also previously served as section head of molecular immunology with the NRC Biotechnology Research Institute in Montreal, and held adjunct faculty appointments with the department of pharmacology and therapeutics at McGill University, and the department of molecular biology and genetics at the University of Guelph.   Dr. Martin holds a Ph.D. in biology from the University of Waterloo, an M.Sc. and B.Sc. in cell biology from the University of Toronto, and completed post-doctoral studies at the Medical Research Council in Cambridge, UK under Dr. Cesar Milstein, FRS, and Nobel Laureate.

Research Interest

 Quaklity Assurance, Biology